Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
13.07
+0.08 (0.62%)
At close: Dec 5, 2025, 4:00 PM EST
12.60
-0.47 (-3.60%)
After-hours: Dec 5, 2025, 7:42 PM EST
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $255.51 million as of December 5, 2025.
Market Cap
255.51M
Enterprise Value
258.23M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.07
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $255.51M, a decrease of -17.25%. That is a compound annual growth rate of -33.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 255.51M | -17.25% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |